Lilly, GE to study cancer therapies

Please subscribe to IBJ to decode this article.

oon-orsir:tNiic>O iYp G.i,b ronr yrla-heaCenLMepstcnls=eFAlG alcdYNeo neadhnlawaRir eds l e khoeiEylvat aley-Iot

suaortearoep e pagadl, aT.criendsflsepecyt hhc uctlmischla sie dgpogrri sep oietotgiekrpfr tewg tieasoah cdhmhcpielm mtdnnoshI nta ;creo t sr esasiptiwoealusieddsl lfperaeetoie deehmnndt yc ephed yncog uspil of nomteaih rw t esl r lcso'gtpcreabptttv soomahl s e uaydtar to rr cueluraresoh gatlhpiihslr essaidtnineaaLeol rnn.o urlnamo edtnltac

ha saymputeitiggastlatleaGnt diti ntns h svd omwci leeoul dlcilsseopic ityitsiodeUtsu.oaelgo elgci'inslnrcr.reer tmEenrdoo nei nfl t lelongr slwt coi rcyg a fcuaeidaaE iaiasem inc l hGen tsmntsie ptL,tss ea glwri ne 'ts oee el Lu iftyl

ircotmuoeta sa nva sclte ul, >iretg eif dyevneeshsr ooansri dt edile f ltc teunaLpnlo sff/hdvfil tnc